Drug Type Small molecule drug |
Synonyms SOK&Q PLUS, 속엔큐플러스정 |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date South Korea (11 Nov 2024), |
Regulation- |
Molecular FormulaC20H38O7S |
InChIKeyHNSDLXPSAYFUHK-UHFFFAOYSA-N |
CAS Registry10041-19-7 |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Abdomen distended | South Korea | 11 Nov 2024 | |
| Anorexia | South Korea | 11 Nov 2024 | |
| Constipation | South Korea | 11 Nov 2024 | |
| Hemorrhoids | South Korea | 11 Nov 2024 | |
| Intestinal Diseases | South Korea | 11 Nov 2024 |





